Liver resection for multimodal treatment of breast cancer metastases: identification of prognostic factors

Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.

Saved in:
Bibliographic Details
Main Authors: Hoffmann, Katrin (Author) , Franz, Clemens (Author) , Hinz, Ulf (Author) , Schirmacher, Peter (Author) , Herfarth, Christian (Author) , Eichbaum, Michael H. R. (Author) , Büchler, Markus W. (Author) , Schemmer, Peter (Author)
Format: Article (Journal)
Language:English
Published: 09 February 2010
In: Annals of surgical oncology
Year: 2010, Volume: 17, Issue: 6, Pages: 1546-1554
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1245/s10434-010-0931-5
Get full text
Author Notes:Katrin Hoffmann, Clemens Franz, Ulf Hinz, Peter Schirmacher, Christian Herfarth, Michael Eichbaum, Markus W. Büchler, and Peter Schemmer
Description
Summary:Liver resection (LR) within a multimodal treatment concept of hepatic metastases (HM) that results from breast cancer has been controversially discussed. The aim of this study was to evaluate the outcome of LR in patients with hepatic breast cancer metastases.
Item Description:Gesehen am 13.03.2023
Physical Description:Online Resource
ISSN:1534-4681
DOI:10.1245/s10434-010-0931-5